Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Recover DS
- Development stage
- Unknown
- Lead developer
- Helax Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Recover DS is an oral rehydration suspension developed and manufactured by Helax Healthcare. It is formulated with sucrose, sodium chloride, and potassium chloride to treat dehydration and electrolyte imbalance resulting from illness or physical exertion. The product is designed to restore essential fluids and electrolytes in patients of all age groups.
- Brand names
- Recover DS
Beyond the preview
Go deeper on Recover DS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Recover DS.